14.09.2018 • NewsDede WillamsInvista

Invista to add 40,000 t of PA 6.6 in China

Invista to add 40,000 t of PA 6.6 in China (c) Invista
Invista to add 40,000 t of PA 6.6 in China (c) Invista

Invista has announced plans to add 40,000 t/y of PA 6.6 polymerization capacity at its plant in Shanghai Chemical Industry Park (SCIP). The Chinese investment will lift output at the site to 190,000 t/y by 2020.

The US polyamide giant headquartered at Wichita, Kansas, already operates a plant for hexamethylenediamine (HMD) at the Shanghai site, producing 215,000 t/y of the feedstock. It is also expected to locate its recently announced adiponitrile (ADN) production facility with capacity of at least 300,000 t/y in the vast chemical park.

Elsewhere, Invista is retrofitting ADN technology at Butachimie, its joint venture with Solvay in France, up to 2019 and is also investing in the nylon feedstock at Victoria, Texas in the US.

Construction is on the PA 6.6 upgrade is due to begin in mid-2019. Invista calculates that it has invested more than $1 billion in its polyamide chain over the past five years. It plans to invest a similar sum going forward, while continuing to evaluate the market for future opportunities, said Pat Brown, vice president of nylon polymer.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.